Skip to main content
Erschienen in: World Journal of Pediatrics 3/2018

24.01.2018 | Original Article

Serum proteomic profiling for autism using magnetic bead-assisted matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a pilot study

verfasst von: Yan-Ni Chen, Hui-Ying Du, Zhuo-Yue Shi, Li He, Yu-Ying He, Duan Wang

Erschienen in: World Journal of Pediatrics | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The pathogenesis of autism spectrum disorders remains elusive and currently there are no diagnostic or predictive biomarkers in autism available. Proteomic profiling has been used in a wide range of neurodevelopmental disorder studies, which could produce deeper perceptions of the molecular bases behind certain disease and potentially becomes useful in discovering biomarkers in autism spectrum disorders.

Methods

Serum samples were collected from autistic children about 3 years old in age (n = 32) and healthy controls (n = 20) in similar age and gender. The samples were identified specific proteins that are differentially expressed by magnetic bead-based pre-fractionation and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-ToF-MS).

Results

Eight protein peaks were significantly different in autistic children from the healthy controls (P < 0.0001). The two peaks with the most significant differences were 6428 and 7758 Da in size.

Conclusion

According to differences in serum protein profiles between the autistic children and healthy controls, this study identified a set of differentially expressed proteins those are significant for further evaluation and might function as biomarkers in autism.
Literatur
1.
Zurück zum Zitat Veenstra-Vanderweele J, Christian SL, Cook EH Jr. Autism as a paradigmatic complex genetic disorder. Annu Rev Genom Hum Genet. 2004;5:379–405.CrossRef Veenstra-Vanderweele J, Christian SL, Cook EH Jr. Autism as a paradigmatic complex genetic disorder. Annu Rev Genom Hum Genet. 2004;5:379–405.CrossRef
2.
Zurück zum Zitat Bertoglio K, Hendren RL. New developments in autism. Psychiatr Clin N Am. 2009;32:1–14.CrossRef Bertoglio K, Hendren RL. New developments in autism. Psychiatr Clin N Am. 2009;32:1–14.CrossRef
3.
Zurück zum Zitat Kim YS, Leventhal BL, Koh Y, Fombonne E, Laska E, Lim E, et al. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry. 2011;168:904–12.CrossRefPubMed Kim YS, Leventhal BL, Koh Y, Fombonne E, Laska E, Lim E, et al. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry. 2011;168:904–12.CrossRefPubMed
6.
Zurück zum Zitat Ozonoff S, Iosif AM, Baguio F, Cook IC, Hill MM, Hutman T, et al. A prospective study of the emergence of early behavioral signs of autism. J Am Acad Child Adolesc Psychiatry. 2010;49:256–66.PubMedPubMedCentral Ozonoff S, Iosif AM, Baguio F, Cook IC, Hill MM, Hutman T, et al. A prospective study of the emergence of early behavioral signs of autism. J Am Acad Child Adolesc Psychiatry. 2010;49:256–66.PubMedPubMedCentral
7.
Zurück zum Zitat Levin Y, Wang L, Ingudomnukul E, Schwarz E, Baron-Cohen S, Palotás A, et al. Real-time evaluation of experimental variation in large-scale LC–MS/MS-based quantitative proteomics of complex samples. J Chromatogr B Anal Technol Biomed Life Sci. 2009;877:1299–305.CrossRef Levin Y, Wang L, Ingudomnukul E, Schwarz E, Baron-Cohen S, Palotás A, et al. Real-time evaluation of experimental variation in large-scale LC–MS/MS-based quantitative proteomics of complex samples. J Chromatogr B Anal Technol Biomed Life Sci. 2009;877:1299–305.CrossRef
8.
Zurück zum Zitat Petricoin EF, Liotta LA. Mass spectrometry-based diagnostics: the upcoming revolution in disease detection. Clin Chem. 2003;49:533–4.CrossRefPubMed Petricoin EF, Liotta LA. Mass spectrometry-based diagnostics: the upcoming revolution in disease detection. Clin Chem. 2003;49:533–4.CrossRefPubMed
9.
Zurück zum Zitat Ngounou Wetie AG, Dekroon RM, Mocanu M, Ryan JP, Darie CC, Woods AG. Mass spectrometry for the study of autism and neurodevelopmental disorders. Adv Exp Med Biol. 2014;806:525–44.CrossRefPubMed Ngounou Wetie AG, Dekroon RM, Mocanu M, Ryan JP, Darie CC, Woods AG. Mass spectrometry for the study of autism and neurodevelopmental disorders. Adv Exp Med Biol. 2014;806:525–44.CrossRefPubMed
10.
Zurück zum Zitat Dudley E, Hässler F, Thome J. Profiling for novel proteomics biomarkers in neurodevelopmental disorders. Expert Rev Proteom. 2011;8:127–36.CrossRef Dudley E, Hässler F, Thome J. Profiling for novel proteomics biomarkers in neurodevelopmental disorders. Expert Rev Proteom. 2011;8:127–36.CrossRef
11.
Zurück zum Zitat Yang J, Yang SY, Hu XY, Huo SF, Shang WL, Li ZF, et al. Serum peptidome profiling in patients with lung cancer. Anat Rec (Hoboken). 2010;293:2027–33.CrossRef Yang J, Yang SY, Hu XY, Huo SF, Shang WL, Li ZF, et al. Serum peptidome profiling in patients with lung cancer. Anat Rec (Hoboken). 2010;293:2027–33.CrossRef
12.
Zurück zum Zitat Diamandis EP. Peptidomics for cancer diagnosis: present and future. J Proteome Res. 2006;5:2079–82.CrossRefPubMed Diamandis EP. Peptidomics for cancer diagnosis: present and future. J Proteome Res. 2006;5:2079–82.CrossRefPubMed
13.
14.
Zurück zum Zitat Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Investig. 2006;116:271–84.CrossRefPubMedPubMedCentral Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Investig. 2006;116:271–84.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Good DM, Thongboonkerd V, Novak J, Bascands JL, Schanstra JP, Coon JJ, et al. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res. 2007;6:4549–55.CrossRefPubMed Good DM, Thongboonkerd V, Novak J, Bascands JL, Schanstra JP, Coon JJ, et al. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res. 2007;6:4549–55.CrossRefPubMed
16.
Zurück zum Zitat Krueger KE, Srivastava S. Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics. Mol Cell Proteom. 2006;5:1799–810.CrossRef Krueger KE, Srivastava S. Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics. Mol Cell Proteom. 2006;5:1799–810.CrossRef
17.
Zurück zum Zitat Fiedler GM, Baumann S, Leichtle A, Oltmann A, Kase J, Thiery J, et al. Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem. 2007;53:421–8.CrossRefPubMed Fiedler GM, Baumann S, Leichtle A, Oltmann A, Kase J, Thiery J, et al. Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem. 2007;53:421–8.CrossRefPubMed
18.
Zurück zum Zitat Schaub NP, Jones KJ, Nyalwidhe JO, Cazares LH, Karbassi ID, Semmes OJ, et al. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients. J Am Coll Surg. 2009;208:970–8 (discussion 978–980).CrossRefPubMed Schaub NP, Jones KJ, Nyalwidhe JO, Cazares LH, Karbassi ID, Semmes OJ, et al. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients. J Am Coll Surg. 2009;208:970–8 (discussion 978–980).CrossRefPubMed
19.
Zurück zum Zitat Schwamborn K, Krieg RC, Grosse J, Reulen N, Weiskirchen R, Knuechel R, et al. Serum proteomic profiling in patients with bladder cancer. Eur Urol. 2009;56:989–96.CrossRefPubMed Schwamborn K, Krieg RC, Grosse J, Reulen N, Weiskirchen R, Knuechel R, et al. Serum proteomic profiling in patients with bladder cancer. Eur Urol. 2009;56:989–96.CrossRefPubMed
20.
Zurück zum Zitat Bailey AR, Giunta BN, Obregon D, Nikolic WV, Tian J, Sanberg CD, et al. Peripheral biomarkers in autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis. Int J Clin Exp Med. 2008;1:338–44.PubMedPubMedCentral Bailey AR, Giunta BN, Obregon D, Nikolic WV, Tian J, Sanberg CD, et al. Peripheral biomarkers in autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis. Int J Clin Exp Med. 2008;1:338–44.PubMedPubMedCentral
21.
Zurück zum Zitat Momeni N, Bergquist J, Brudin L, Behnia F, Sivberg B, Joghataei MT, et al. A novel blood-based biomarker for detection of autism spectrum disorders. Transl Psychiatry. 2012;2:e91.CrossRefPubMedPubMedCentral Momeni N, Bergquist J, Brudin L, Behnia F, Sivberg B, Joghataei MT, et al. A novel blood-based biomarker for detection of autism spectrum disorders. Transl Psychiatry. 2012;2:e91.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Taurines R, Dudley E, Conner AC, Grassl J, Jans T, Guderian F, et al. Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry. Eur Arch Psychiatry Clin Neurosci. 2010;260:249–55.CrossRefPubMed Taurines R, Dudley E, Conner AC, Grassl J, Jans T, Guderian F, et al. Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry. Eur Arch Psychiatry Clin Neurosci. 2010;260:249–55.CrossRefPubMed
23.
Zurück zum Zitat Ramsey JM, Guest PC, Broek JA, Glennon JC, Rommelse N, Franke B, et al. Identification of an age-dependent biomarker signature in children and adolescents with autism spectrum disorders. Mol Autism. 2013;4:27.CrossRefPubMedPubMedCentral Ramsey JM, Guest PC, Broek JA, Glennon JC, Rommelse N, Franke B, et al. Identification of an age-dependent biomarker signature in children and adolescents with autism spectrum disorders. Mol Autism. 2013;4:27.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Steeb H, Ramsey JM, Guest PC, Stocki P, Cooper JD, Rahmoune H, et al. Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome. Mol Autism. 2014;5:4.CrossRefPubMedPubMedCentral Steeb H, Ramsey JM, Guest PC, Stocki P, Cooper JD, Rahmoune H, et al. Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome. Mol Autism. 2014;5:4.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Schwarz E, Guest PC, Rahmoune H, Wang L, Levin Y, Ingudomnukul E, et al. Sex-specific serum biomarker patterns in adults with Asperger’s syndrome. Mol Psychiatry. 2011;16:1213–20.CrossRefPubMed Schwarz E, Guest PC, Rahmoune H, Wang L, Levin Y, Ingudomnukul E, et al. Sex-specific serum biomarker patterns in adults with Asperger’s syndrome. Mol Psychiatry. 2011;16:1213–20.CrossRefPubMed
Metadaten
Titel
Serum proteomic profiling for autism using magnetic bead-assisted matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a pilot study
verfasst von
Yan-Ni Chen
Hui-Ying Du
Zhuo-Yue Shi
Li He
Yu-Ying He
Duan Wang
Publikationsdatum
24.01.2018
Verlag
Childrens Hospital, Zhejiang University School of Medicine
Erschienen in
World Journal of Pediatrics / Ausgabe 3/2018
Print ISSN: 1708-8569
Elektronische ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-017-0102-x

Weitere Artikel der Ausgabe 3/2018

World Journal of Pediatrics 3/2018 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.